🧬 GEFFON Gefitinib 250 mg Tablets
🔹 Introduction
Gefitinib 250 mg tablets (brand: GEFFON) are targeted anti-cancer medicines used mainly for treating non-small cell lung cancer (NSCLC). These tablets belong to a class called tyrosine kinase inhibitors (TKIs) and are widely used in patients with EGFR mutations.
🔬 Composition & Content
- Active Ingredient: Gefitinib 250 mg
- Drug Class: EGFR Tyrosine Kinase Inhibitor
- Form: Oral tablet
How it works:
Gefitinib blocks the epidermal growth factor receptor (EGFR), which helps stop cancer cell growth and division.💊 Uses & Treatments
GEFFON Gefitinib 250 mg is primarily used for:
- ✔️ Non-Small Cell Lung Cancer (NSCLC)
- ✔️ EGFR mutation-positive lung cancer
- ✔️ Advanced or metastatic lung cancer
- ✔️ First-line targeted therapy in eligible patients
👉 Especially effective in tumors with:
- Exon 19 deletions
- Exon 21 (L858R) mutations
📌 Dosage & How to Use
- Standard Dose: 250 mg once daily
- Take with or without food
- Swallow whole with water
- Continue treatment as advised by oncologist
⚠️ Dose adjustments may be needed based on:
- Side effects
- Liver function
- Patient tolerance
⚙️ How It Works (Mechanism)
- Targets EGFR protein on cancer cells
- Blocks tumor signaling pathways
- Slows or stops cancer progression
👉 This is precision medicine, meaning it works best in genetically selected patients.
✅ Advantages
- ✔️ Oral therapy (no hospitalization needed)
- ✔️ Targeted action (less damage to healthy cells)
- ✔️ Better tolerability than chemotherapy
- ✔️ Improves progression-free survival in EGFR-positive patients
- ✔️ Convenient once-daily dosing
⚠️ Possible Side Effects
Common side effects include:
- Skin rash
- Diarrhea
- Nausea & vomiting
- Loss of appetite
- Weakness
👉 Serious (rare):
- Lung inflammation (interstitial lung disease)
- Liver toxicity
🧊 Storage Conditions
- Store below 25–30°C
- Keep away from moisture & sunlight
- Store in original packaging
- Keep out of reach of children
🇮🇳 Alternative Indian Brands (Gefitinib 250 mg)
Here are widely available same-composition alternatives:
- Geftinat 250 mg Tablet (Natco Pharma)
- Gefticip 250 mg Tablet (Cipla Ltd)
- Geftibenz 250 Tablet
- Geftisym 250 Tablet
- Gefshil 250 Tablet
- K-Gef 250 mg Tablet
👉 All contain Gefitinib 250 mg and are used for the same indication.
🌍 Global Demand & Export Relevance
Gefitinib is highly demanded in:
- Saudi Arabia (Riyadh, Jeddah, Mecca, Medina, Dammam)
- USA, UK, UAE, Europe
- Southeast Asia & Africa
👉 Due to affordability and availability, Indian generics are preferred worldwide.
📦 Advantages for Export (GlobMedIndia)
- WHO-GMP compliant manufacturing
- Cost-effective generic versions
- Bulk supply capability
- Fast global shipping
- Reliable oncology portfolio
💊 Order GEFFON Gefitinib 250 mg Tablets Online – Trusted Anti-Cancer Medicine Supplier
Buy GEFFON Gefitinib 250 mg Tablets at the best price from GlobMedIndia – a leading exporter of high-quality oncology medicines from India. Gefitinib is a targeted therapy used for EGFR-positive non-small cell lung cancer (NSCLC), offering effective and convenient oral treatment.
🌍 We deliver globally:
Saudi Arabia (Riyadh, Jeddah, Mecca, Medina, Dammam), UAE, USA, UK, Europe, Australia, Africa, Southeast Asia, and more.
✅ 100% Genuine Medicines
✅ WHO-GMP Certified Suppliers
✅ Fast & Safe International Delivery
✅ Competitive Wholesale Prices
💡 Also available alternatives: Geftinat, Gefticip, Gefshil, Geftisym, K-Gef
📦 Order now from GlobMedIndia – Your Trusted Global Medicine Exporter
#Gefitinib #LungCancerTreatment #AntiCancerMedicines #OncologyDrugs #GlobMedIndia #TargetedTherapy #NSCLC #CancerCare #PharmaExporter #BuyMedicinesOnline #SaudiArabia #UAE #USA #UK #Europe #IndiaPharmacy
🧾 Conclusion
GEFFON Gefitinib 250 mg Tablets is a highly effective targeted cancer therapy for EGFR-positive lung cancer patients. With strong clinical benefits, oral convenience, and multiple affordable Indian alternatives, it remains a preferred global oncology drug—especially in export markets.
